Back to Search
Start Over
273TiP ACE-Breast-03: A phase II study patients with HER2-positive metastatic breast cancer whose disease is resistant or refractory to T-DM1, and/or T-DXd, and/or tucatinib-containing regimens treated with ARX788
- Source :
- Annals of Oncology. 33:S662-S663
- Publication Year :
- 2022
- Publisher :
- Elsevier BV, 2022.
- Subjects :
- Oncology
Hematology
Subjects
Details
- ISSN :
- 09237534
- Volume :
- 33
- Database :
- OpenAIRE
- Journal :
- Annals of Oncology
- Accession number :
- edsair.doi...........1ffabd9dbcc0cf0a0b9ea2e3e434d06d
- Full Text :
- https://doi.org/10.1016/j.annonc.2022.07.1857